On this page
Study tools
Prompt
Write your answer
Saved on this device. No marking — you are the marker.
Q1: Definition and triad (2 min)
Define Sézary syndrome within CTCL. State the classic triad and typical immunophenotype of Sézary cells.
Q2: Differential of erythroderma (3 min)
How would you distinguish SS from atopic erythroderma, psoriasis, drug reaction, and erythrodermic MF?
Q3: Investigations and TNMB (2 min)
What blood tests confirm B2 involvement? Map classic SS to TNMB stage (IVA1 concept).
Q4: Management algorithm (3 min)
Outline multimodal therapy: skin care, ECP, interferon/bexarotene/methotrexate, mogamulizumab, HDAC inhibitors, brentuximab if CD30+, TSEBT, and allo-HSCT.
Q5: Complications and prognosis (2 min)
What infectious and treatment-related complications matter most? How does prognosis compare with early mycosis fungoides?